当前位置:主页 > 医学论文 > 心血管论文 >

非瓣膜性房颤患者慢性肾脏病对死亡、血栓终点事件及房颤负荷的影响

发布时间:2018-04-29 03:00

  本文选题:心房颤动 + 慢性肾功能不全 ; 参考:《中国人民解放军医学院》2015年博士论文


【摘要】:第一部分中老年非瓣膜性房颤患者肾功能不全对死亡、心脑血管死亡及血栓终点事件的影响目的:本研究拟探讨肾功能不全是否为非瓣膜性房颤患者脑卒中等血栓栓塞性事件、全因死亡、心脑血管死亡等终点事件的独立危险因素。方法:回顾性研究于2008年7月至2011年6月在中国人民解放军总医院住院治疗的中老年非瓣膜性心房颤动患者825例,记录一般情况、基础疾病、实验室检查、超声心动图等基线特征及观测期间内全因死亡、心脑血管死亡及血栓终点事件发生情况。根据基线肾小球滤过率将入选患者分组,分别进行Logistic多因素分析及Cox生存分析比较肾功能不全的危险因素及其对各终点事件的影响。结果:入选的825例未行抗凝治疗的中老年非瓣膜性房颤患者慢性肾功能不全 (eGFR60ml/min/1.73m2)的患病率为21.09%,年龄≥75岁、女性、2型糖尿病、心力衰竭及左室肥厚是入选房颤患者发生慢性肾功能不全的独立危险因素。入选患者平均随访时间为33.16±22.24月,共观测2279.58人年。随访期间发生全因死亡209例、心脑血管死亡61例、血栓终点事件(脑卒中/TIA/外周动脉栓塞)139例及心血管事件(急性心肌梗死/急性左心衰)133例。合并慢性肾功能不全的房颤患者的全因死亡、心脑血管死亡、血栓事件及心血管事件发生率均显著高于未合并慢性肾功能不全的房颤患者,在校正CHA2DS2-VASc评分后,慢性肾功能不全仍是全因死亡(HR:1.794,95%CI:1.330-2.419, P0.001),心血管死亡(HR:2.865, 95%CI:1.706-4.811, P0.001)、血栓事件(HR:1.636,95%CI:1.121-2.388, P=0.011)及心血管事件(HR:2.371,95%CI:1.651-3.404, P0.001)的独立预测因素。此外,左房增大(LAVI40ml/m2)是血栓栓塞事件、全因死亡及心血管事件的独立危险因素,而与心脑血管死亡无显著相关。结论:慢性肾功能不全是中老年非瓣膜性房颤患者全因死亡、心脑血管死亡、血栓事件及心血管事件的独立危险因素,且不依赖于CHADS2评分及CHA2DS2VASc评分。左房增大也与全因死亡、血栓事件及心血管事件独立相关。第二部分血清胱抑素C对不伴有慢性肾功能不全的老年房颤患者的死亡及血栓终点事件的影响目的:本研究拟探讨在不伴有慢性肾功能不全(eGFR60ml/min/1.73m2)的老年房颤患者中,血清胱抑素C对全因死亡、心脑血管死亡、血栓终点事件及心血管事件的影响。方法:回顾性研究于2008年7月至2010年6月在中国人民解放军总医院住院治疗且基线资料完整的60岁以上老年非瓣膜性心房颤动患者356例,记录基线特征及观测期间内全因死亡、心脑血管死亡及血栓终点事件发生情况。根据入选老年房颤患者基线血清胱抑素C水平的中位数(1.15mg/L)进行分组,分别进行Logistic多因素分析及Cox生存分析比较血清胱抑素C升高的危险因素及其对各终点事件的影响。结果:入选的356例不伴有慢性肾功能不全的老年非瓣膜性房颤患者平均随访37.83±21.87月,发现基线血清胱抑素c水平与尿酸氮、血肌酐及肾小球滤过率密切相关,年龄≥75岁、吸烟、心力衰竭及左室肥厚是入选房颤患者血清胱抑素C升高的独立危险因素。随访期间共发生全因死亡97例、心脑血管死亡27例、血栓终点事件共74例及心血管终点事件56例。在校正多种传统心血管危险因素后,血清胱抑素C升高能够独立预测不伴有慢性肾功能不全的老年非瓣膜性房颤患者的全因死亡率(HR:1.936,95%CI:1.247-3.008, P=0.003)、心脑血管死亡率(HR:3.695, 95%CI:1.536-8.889, P=0.004)、血栓事件(脑卒中/TIA/外周动脉栓塞)(HR:1.725, 95%CI:1.055-2.819, P=0.030)和心血管事件(急性心肌梗死/急性左心衰)(HR:2.184, 95%CI:1.197-3984, P=0.011)的发生。结论:血清胱抑素c升高可以独立预测不伴肾功能不全的老年非瓣膜性房颤患者的全因死亡、心脑血管死亡、血栓事件及心血管事件等终点事件的发生。第三部分心脏起搏器植入术后的老年阵发性房颤患者肾功能不全、左房容积指数及房颤负荷与血栓事件的相关研究目的:本研究拟了解植入起搏器的老年阵发性房颤患者再发房颤(包括无症状性房颤)的发生率及房颤负荷,探讨房颤负荷的影响因素,初步分析肾功能不全、房颤负荷及左房容积指数对脑卒中等血栓事件的影响。方法:对2012年1月至2013年12月在我院起搏器门诊长期随访的连续老年阵发性房颤患者148例进行前瞻性观察研究,记录基线特征及随访期间内房颤及血栓事件等临床终点事件发生情况。根据照入选老年房颤患者的房颤负荷进行分组,分别进行Logistic多因素分析及Cox生存分析比较慢性肾功能不全、左房容积指数及房颤负荷对血栓终点事件的影响。建立新的血栓评分标准,并应用曲线下面积比较不同评分标准对血栓终点事件的预测能力。结果:所有患者平均随访时间为22.79±7.03月,85例患者再发房颤(57.43%),34例患者为房颤高负荷(22.97%),发生无症状房颤的患者为23例(15.54%)。多因素Logistic回归分析发现左房增大分别是再发房颤(OR:3.524,95%CI: 1.339-9.276)及房颤高负荷(OR:8.110,95%CI:3.000-21.918)的独立危险因素。在校正CHADS2评分基础上,慢性肾功能不全(eGFR60 ml/min/1.73m2)和左房增大(LAVI28ml/m2)仍是血栓事件的独立危险因素。将肾功能不全(R)和左房增大(L)引入CHADS2评分及CHA2DS2-VASc评分,发现R2CHADS2L评分和R2CHA2DS2-VAScL评分预测血栓事件的C值分别为0.740 (95%CI:0.655-0.826) 和0.749(95%CI:0.671-0.816),显著高于CHADS2评分,但并不优于CHA2DS2-VASc评分。而单独将慢性肾功能不全纳入CHADS2评分或CHA2DS2-VASc评分并不能提高血栓事件预测效能。结论:左房增大是预测房颤复发及房颤高负荷的危险因素,R2CHADS2L评分和R2CHA2DS2-VAScL评分预测血栓事件的效能高于CHADS2评分,但并不优于CHA2DS2-VASc评分。
[Abstract]:Part 1: the effect of renal insufficiency on death, cardiac and cerebral vascular death and thrombus terminal event in middle-aged and elderly patients with non valvular atrial fibrillation. The purpose of this study is to explore whether renal insufficiency is an independent risk factor for thromboembolic events such as stroke in patients with non valvular atrial fibrillation, all causes of death, cardiac and cerebral blood tube death. Methods: a retrospective study was conducted in 825 patients with middle and old non valvular atrial fibrillation hospitalized in General Hospital of PLA from July 2008 to June 2011. The baseline features, basic diseases, laboratory tests, echocardiography, and all causes of death during observation, cardiac and cerebrovascular death and the occurrence of thrombus end point were recorded. Conditions. According to the baseline glomerular filtration rate, the patients were divided into groups. Logistic multivariate analysis and Cox survival analysis were used to compare the risk factors of renal insufficiency and their impact on the endpoint events. Results: 825 Cases of non valvular atrial fibrillation patients who were not treated with anticoagulant therapy were selected for chronic renal failure (eGFR60ml/min/1.7 The prevalence of 3M2 was 21.09%, age over 75 years, women, type 2 diabetes, heart failure and left ventricular hypertrophy were independent risk factors for chronic renal dysfunction in patients with atrial fibrillation. The average follow-up time was 33.16 + 22.24 months, and 2279.58 years were observed. 209 cases of total death, 61 cases of cardiovascular and cerebrovascular deaths, and thrombus were observed during the follow-up period. 139 cases and 133 cases of cardiovascular events (acute myocardial infarction / acute left heart failure) in 139 cases and 133 cases of cardiovascular events (acute myocardial infarction / acute left heart failure). Patients with atrial fibrillation with chronic renal insufficiency were dead, cardiac and cerebrovascular death, thrombus events and cardiovascular events were significantly higher than those without chronic renal failure. After the CHA2DS2-VASc score, chronic renal insufficiency was still an independent predictor of all causes (HR:1.794,95%CI:1.330-2.419, P0.001), cardiovascular death (HR:2.865, 95%CI:1.706-4.811, P0.001), thrombotic events (HR:1.636,95%CI:1.121-2.388, P=0.011) and cardiovascular events (HR: 2.371,95%CI:1.651-3.404, P0.001). Moreover, the left atrial enlargement (LAV) was enlarged (LAV). I40ml/m2) is a thromboembolism event that has no significant correlation with cardiovascular and cerebrovascular deaths due to independent risk factors for death and cardiovascular events. Conclusion: chronic renal insufficiency is an independent risk factor for patients with middle aged non valvular atrial fibrillation, cardiovascular and cerebrovascular death, thrombus events and cardiovascular events, and is not dependent on the CHADS2 evaluation. Scores and CHA2DS2VASc scores. Left atrial enlargement was also independent of all causes of death, thrombus events and cardiovascular events. Second the effect of serum cystatin C on death and thrombus terminal events in elderly patients with atrial fibrillation without chronic renal insufficiency (eGFR60ml/min/1.73m2): This study was to be explored without chronic renal insufficiency (eGFR60ml/min/1.73m2 In the elderly patients with atrial fibrillation, serum cystatin C was affected by all causes of death, cardiac and cerebrovascular death, thrombus terminal events and cardiovascular events. Methods: a retrospective study was conducted in 356 cases of non valvular atrial fibrillation who were hospitalized in General Hospital of PLA from July 2008 to June 2010, with complete baseline data of 60 years old and older non valvular atrial fibrillation. Baseline characteristics and total cause of death, cardiovascular and cerebrovascular death and the occurrence of thrombus terminal events during the observation period. According to the median of the baseline serum cystatin C (1.15mg/L) in the elderly patients who were selected, the Logistic multifactor analysis and Cox survival analysis were used to compare the risk factors for the increase of serum cystatin C and the risk factors for the increase of serum cystatin C Results: the average follow-up of 356 elderly non valvular atrial fibrillation patients without chronic renal insufficiency was 37.83 + 21.87 months. The baseline serum cystatin C level was closely related to uric acid nitrogen, blood creatinine and glomerular filtration rate, age more than 75 years, smoking, heart failure and left ventricular hypertrophy were selected as atrial fibrillation. An independent risk factor for elevated serum cystatin C. 97 cases of total cause of death, 27 cases of cardiovascular and cerebrovascular death, 74 cases of thrombus terminal event and 56 cases of cardiovascular endpoint events were observed during the follow-up period. After correcting a variety of traditional cardiovascular risk factors, serum cystatin C could be independently pretested for non chronic renal insufficiency All cause mortality (HR:1.936,95%CI:1.247-3.008, P=0.003), cardiac and cerebrovascular mortality (HR:3.695, 95%CI:1.536-8.889, P=0.004), thrombus event (/TIA/ peripheral arterial embolism) (HR:1.725, 95%CI:1.055-2.819, P=0.030) and cardiac vascular events (acute myocardial infarction / acute Zuo Xinshuai) (HR:2.184, 95%CI:1.197-3984). Conclusion: the rise of serum cystatin C can independently predict all causes of death, cardiovascular and cerebrovascular death, thrombus events and cardiovascular events in elderly patients with non valvular atrial fibrillation without renal insufficiency. Third patients with paroxysmal atrial fibrillation after cardiac pacemaker implantation in third patients have renal insufficiency, The correlation of left atrial volume index and atrial fibrillation load and thrombotic events. Objective: To investigate the incidence of recurrent atrial fibrillation (including asymptomatic atrial fibrillation) and atrial fibrillation load in patients with paroxysmal atrial fibrillation (PAF) implanted in the pacemaker, to explore the factors affecting the atrial fibrillation load, to analyze the renal insufficiency, the atrial fibrillation load and the left atrial volume index. Methods: a prospective study of 148 consecutive patients with paroxysmal atrial fibrillation in the outpatient department of pacemaker from January 2012 to December 2013. The baseline features and the occurrence of clinical endpoints such as atrial fibrillation and thrombotic events during the follow-up period were recorded. Logistic multifactor analysis and Cox survival analysis were used to compare the effects of chronic renal insufficiency, left atrial volume index and atrial fibrillation load on thrombus terminal events. A new standard of thrombus score was established, and the predictive ability of different scoring criteria on thrombus terminal events was applied. All patients were followed up with an average of 22.79 + 7.03 months, 85 patients with atrial fibrillation (57.43%), 34 patients with atrial fibrillation (22.97%), 23 patients with asymptomatic atrial fibrillation (15.54%). Multiple factor Logistic regression analysis found that the left atrial enlargement was OR:3.524,95%CI: 1.339-9.276 and the high load of atrial fibrillation (OR:8.110,95%CI: Independent risk factors of 3.000-21.918). On the basis of correction of CHADS2 score, chronic renal insufficiency (eGFR60 ml/min/1.73m2) and left atrial enlargement (LAVI28ml/m2) are still an independent risk factor for thrombus events. Renal dysfunction (R) and left atrial enlargement (L) were introduced into CHADS2 score and CHA2DS2-VASc score, and R2CHADS2L score and R2CHA2DS2-VAScL evaluation were found. The C values were 0.740 (95%CI:0.655-0.826) and 0.749 (95%CI:0.671-0.816), respectively, which were significantly higher than the CHADS2 score, but not better than the CHA2DS2-VASc score. However, it was not better to integrate the chronic renal insufficiency into the CHADS2 score or the CHA2DS2-VASc score. Conclusion: the left atrial enlargement is the prediction of atrial fibrillation. The risk factors of relapse and high load of atrial fibrillation, R2CHADS2L score and R2CHA2DS2-VAScL score were more effective than CHADS2 scores, but it was not better than the CHA2DS2-VASc score.

【学位授予单位】:中国人民解放军医学院
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R541.75;R692

【相似文献】

相关期刊论文 前10条

1 周雄根,陈敏,赵峻;中药治疗慢性肾功能不全者抑郁症疗效观察[J];长春中医学院学报;2000年01期

2 程鸿鸣;慢性肾功能不全12例误诊分析[J];实用乡村医生杂志;2000年01期

3 杨绪绣;中药保留灌肠治疗急慢性肾功能不全43例临床疗效分析[J];华夏医学;2000年03期

4 曾文,张广宇,付淑霞,王彦,李松;血管紧张素转换酶基因多态性与慢性肾功能不全[J];河北医药;2000年01期

5 冯文学,李希科,詹美兰,吴利军;大黄治疗慢性肾功能不全25例的疗效分析[J];河南医药信息;2000年02期

6 陶雅非,马树勋,任东升;木通中毒致慢性肾功能不全的临床观察[J];河南大学学报(医学科学版);2001年04期

7 杨凌,胡敏燕,侯凡凡,余跃明,张明,付春梅;慢性肾功能不全患者血浆同型半胱氨酸水平检测[J];中国临床药学杂志;2001年05期

8 梁艳,朱清,程银祯;慢性肾功能不全患者血脂代谢紊乱临床分析[J];中原医刊;2001年09期

9 姚沛;慢性肾功能不全33例临床分析[J];农垦医学;2001年01期

10 张杰玉;147例慢性肾功能不全的预后分析[J];现代医药卫生;2001年03期

相关会议论文 前10条

1 陈惠彬;史振玉;;低蛋白淀粉饮食治疗慢性肾功能不全疗效观察[A];中国营养学会第六届临床营养学术会议论文摘要汇编[C];1997年

2 刘世培;;中西医结合治疗慢性肾功能不全30例的体会[A];第七届全国中西医结合肾脏病会议论文汇编[C];2003年

3 刘其刚;;中西医结合治疗56例慢性肾功能不全疗效观察[A];第七届全国中西医结合肾脏病会议论文汇编[C];2003年

4 韩维嘉;陈艳秋;沈雅英;李士捷;张俊;肖菲;孙建琴;;住院老年慢性肾功能不全患者的营养状况[A];中国营养学会第九次全国营养学术会议论文摘要汇编[C];2004年

5 徐玉兰;;逆转慢性肾功能不全[A];浙江省肾脏病骨干医师学术研讨会论文汇编[C];2005年

6 王绍霞;;恶性肿瘤患者合并慢性肾功能不全的饮食指导[A];全国第6届糖尿病护理学术交流暨专题讲座会议、全国第6届血液净化护理学术交流暨专题讲座会议论文汇编[C];2008年

7 刘路鹏;钱叶勇;齐宝玉;常京元;范宇;许晓东;;慢性肾功能不全合并无典型症状横纹肌溶解综合征1例及文献复习[A];2012中国器官移植大会论文汇编[C];2012年

8 董飞侠;;提高慢性肾功能不全疗效的思路[A];首届“之江中医药论坛”暨浙江省中医药学会2011年学术年会论文集[C];2011年

9 赵宏波;张振忠;;张振忠教授治疗慢性肾功能不全经验[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(上)[C];2008年

10 张汀;;慢性肾功能不全病人饮食疗效观察[A];四川省营养学会成立十周年纪念暨1998年学术会议专题报告及论文摘要汇编[C];1998年

相关重要报纸文章 前10条

1 孙雪松;慢性肾功能不全的“营养药”[N];中国医药报;2006年

2 市第二人民医院肾内科主任 朱承松;慢性肾功能不全的早期发现和治疗[N];镇江日报;2008年

3 王会玲医学博士、副主任医师;慢性肾功能不全者饮食有讲究[N];上海中医药报;2005年

4 ;中西医结合治疗慢性肾功能不全疗效确切[N];中国中医药报;2004年

5 通讯员  黄治才 宁习源 记者  于莘明;慢性肾功能不全治疗策略有望改变[N];科技日报;2006年

6 柳维刚;慢性肾功能不全误诊为慢性胃病浅析[N];农村医药报(汉);2006年

7 本报记者 谭允;饮食治疗慢性肾功能不全[N];广东科技报;2008年

8 ;肾衰宁胶囊延缓慢性肾功能不全[N];中国中医药报;2003年

9 北京大学人民医院主任医师 王少杰;慢性肾衰并非不可控[N];健康报;2009年

10 ;特色治疗让患者生存质量更高[N];本溪日报;2009年

相关博士学位论文 前3条

1 涂玲;重组腺相关病毒介导人激肽释放酶基因治疗慢性肾功能不全及其机制研究[D];华中科技大学;2006年

2 郑艳辉;益肾清利和络泄浊法治疗慢性肾功能不全临床研究[D];南京中医药大学;2007年

3 王海军;非瓣膜性房颤患者慢性肾脏病对死亡、血栓终点事件及房颤负荷的影响[D];中国人民解放军医学院;2015年

相关硕士学位论文 前10条

1 周敬;自体诱导性多能干细胞移植治疗慢性肾功能不全的研究[D];昆明医学院;2011年

2 张田学忠;芪归升降散治疗慢性肾功能不全的临床观察[D];北京中医药大学;2007年

3 王顺;农村维吾尔族牙周炎与慢性肾功能不全相关性的初步研究[D];新疆医科大学;2009年

4 罗娟;小儿慢性肾功能不全的临床分析[D];重庆医科大学;2010年

5 杨莉;脑卒中合并慢性肾功能不全危险因素调查[D];新疆医科大学;2012年

6 黄婧文;肾康注射液治疗脾肾两虚、瘀浊内阻型老年慢性肾功能不全的临床疗效观察[D];山东中医药大学;2014年

7 于亚萍;慢性肾功能不全阳虚证治疗法则及作用原理的临床研究[D];南京中医药大学;2010年

8 陈雪;465例慢性肾功能不全患者中医证候研究[D];北京中医药大学;2011年

9 李影;高效液相色谱—荧光法同时测定慢性肾功能不全患者血清中芳香族氨基酸[D];中南大学;2011年

10 章子铭;超声评价慢性肾功能不全患者心血管结构及功能改变[D];华中科技大学;2013年



本文编号:1818068

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/xxg/1818068.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户83784***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com